Bulk Manufacturer of Controlled Substances Registration; Siemens Healthcare Diagnostics, Inc., 52135 [2019-21313]

Download as PDF 52135 Federal Register / Vol. 84, No. 190 / Tuesday, October 1, 2019 / Notices Dated: September 23, 2019. Thomas W. Prevoznik, Acting Assistant Administrator, Deputy Assistant Administrator. DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] [FR Doc. 2019–21320 Filed 9–30–19; 8:45 am] Bulk Manufacturer of Controlled Substances Registration BILLING CODE 4410–09–P ACTION: Notice of registration. SUMMARY: The registrants listed below have applied for and been granted a Company FR docket Absolute Standards, Inc ............................................................................. Pisgah Laboratories, Inc ............................................................................ 84 FR 31620 ....................................................... 84 FR 31622 ....................................................... The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a [FR Doc. 2019–21312 Filed 9–30–19; 8:45 am] SUPPLEMENTARY INFORMATION: BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] 18:10 Sep 30, 2019 Jkt 250001 The companies listed below applied to be registered as a bulk manufacturer of a basic class of schedule I and II controlled substances. Information on previously published notices is listed below. No comments or objections were submitted for the notice. Bulk Manufacturer of Controlled Substances Registration; Siemens Healthcare Diagnostics, Inc. ACTION: Notice of registration. FR Docket The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each of the company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR July 2, 2019. July 2, 2019. Dated: September 24, 2019. Thomas W. Prevoznik, Acting Assistant Administrator, Deputy Assistant Administrator. Siegfried USA, LLC .................................................................................... Patheon Pharmaceuticals, Inc ................................................................... S & B Pharma Inc ...................................................................................... Siemens Healthcare Diagnostics, Inc ........................................................ Synthcon, LLC ........................................................................................... VerDate Sep<11>2014 Published SUMMARY: The registrants listed below have applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances. registration as a bulk manufacturer to the above listed companies. Company jbell on DSK3GLQ082PROD with NOTICES registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of a various classes of schedule I and II controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as a bulk manufacturer of various classes of scheduled I and II controlled substances. Information on a previously published notices is listed below. No comments or objections were submitted for these notices. 84 84 84 84 84 FR FR FR FR FR Published 7129 ......................................................... 8114 ......................................................... 8116 ......................................................... 10534 ....................................................... 13962 ....................................................... March 1, 2019. March 6, 2019. March 6, 2019. March 21, 2019. April 8, 2019. 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies. DEPARTMENT OF JUSTICE Dated: September 23, 2019. Thomas W. Prevoznik, Acting Assistant Administrator, Deputy Assistant Administrator. [Docket No. DEA–392] [FR Doc. 2019–21313 Filed 9–30–19; 8:45 am] ACTION: Drug Enforcement Administration Importer of Controlled Substances Application: Noramco, Inc. Notice of application. BILLING CODE 4410–09–P PO 00000 Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 31, 2019. Such persons may also file a written request for a hearing on the application on or before October 31, 2019. DATES: Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\01OCN1.SGM 01OCN1

Agencies

[Federal Register Volume 84, Number 190 (Tuesday, October 1, 2019)]
[Notices]
[Page 52135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21313]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration; Siemens 
Healthcare Diagnostics, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrants listed below have applied for and been granted 
a registration by the Drug Enforcement Administration (DEA) as a bulk 
manufacturer of various classes of schedule I and II controlled 
substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as a bulk manufacturer of a basic class of schedule I and II 
controlled substances. Information on previously published notices is 
listed below. No comments or objections were submitted for the notice.

------------------------------------------------------------------------
           Company                FR Docket             Published
------------------------------------------------------------------------
Siegfried USA, LLC...........  84 FR 7129.....  March 1, 2019.
Patheon Pharmaceuticals, Inc.  84 FR 8114.....  March 6, 2019.
S & B Pharma Inc.............  84 FR 8116.....  March 6, 2019.
Siemens Healthcare             84 FR 10534....  March 21, 2019.
 Diagnostics, Inc.
Synthcon, LLC................  84 FR 13962....  April 8, 2019.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of these registrants to manufacture 
the applicable basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each of the company's maintenance of 
effective controls against diversion by inspecting and testing each 
company's physical security systems, verifying each of the company's 
compliance with state and local laws, and reviewing each company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed companies.

    Dated: September 23, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy Assistant Administrator.
[FR Doc. 2019-21313 Filed 9-30-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.